Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 22, 2026 Filed Jun 25, 2026 20:59 UTC |
AJJARAPU SURENDRA KDirector
|
OtherWarrant · Derivative | 100,000 | $0.00 Strike: $0.01 | $0.00 |
DisclosureSEC source: 0001493152-26-030154 · ownership.xml · derivative · entry 2 AJJARAPU SURENDRA K · CIK 0001368298 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 100,000 shares Expires 2031-03-31 Read SEC document |
| June 22, 2026 Filed Jun 25, 2026 20:59 UTC |
AJJARAPU SURENDRA KDirector
|
OtherCommon Stock | 100,000 | $0.01 | $500.00 |
DisclosureSEC source: 0001493152-26-030154 · ownership.xml · nonDerivative · entry 1 AJJARAPU SURENDRA K · CIK 0001368298 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 257,645 F1 · shares: Represents the conversion of warrants (the "Warrants") issued to the Reporting Person on 3/31/2026 in lieu of cash compensation due to the Reporting Person. F2 · balance_after: Reflects the aggregate amount of Common Stock held by the Reporting Person following the Issuer's reverse stock split, effective May 26, 2026, as well as the Common Stock issued pursuant to the conversion of the Warrants. Read SEC document |
| June 22, 2026 Filed Jun 25, 2026 20:57 UTC |
Patel PrashantDirector · Chief Executive Officer
|
OtherWarrant · Derivative | 100,000 | $0.00 Strike: $0.01 | $0.00 |
DisclosureSEC source: 0001493152-26-030151 · ownership.xml · derivative · entry 2 Patel Prashant · CIK 0001617460 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 100,000 shares Expires 2031-03-31 F2 · shares: Reflects the aggregate amount of Common Stock held by the Reporting Person following the Issuer's reverse stock split, effective May 26, 2026, as well as the Common Stock issued pursuant to the conversion of the Warrants. Read SEC document |
| June 22, 2026 Filed Jun 25, 2026 20:57 UTC |
Patel PrashantDirector · Chief Executive Officer
|
OtherCommon Stock | 100,000 | $0.01 | $500.00 |
DisclosureSEC source: 0001493152-26-030151 · ownership.xml · nonDerivative · entry 1 Patel Prashant · CIK 0001617460 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 282,365 F1 · shares: Represents the conversion of warrants (the "Warrants") issued to the Reporting Person on 3/31/2026 in lieu of cash compensation due to the Reporting Person. Read SEC document |
| March 31, 2026 Filed Apr 24, 2026 00:55 UTC |
Patel PrashantDirector · Chief Executive Officer
|
GrantWarrant · Derivative | 5,000,000 | $0.01 Strike: $0.01 | $50,000.00 |
DisclosureSEC source: 0001493152-26-018820 · ownership.xml · derivative · entry 2 Patel Prashant · CIK 0001617460 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,000,000 Underlying: Common Stock · 5,000,000 shares Expires 2031-03-31 F2 · shares: The Issuer issued the Reporting Person 5,000,000 warrants to purchase common stock (the "Warrants") as compensation for the Reporting Person's service to the Issuer. The Warrants were issued in a transaction exempt from registration under Section 4(a)(2) of the Securities Act of 1933. Read SEC document |
| March 31, 2026 Filed Apr 24, 2026 00:55 UTC |
Patel PrashantDirector · Chief Executive Officer
|
GrantCommon Stock | 5,000,000 | $0.20 | $1,000,000.00 |
DisclosureSEC source: 0001493152-26-018820 · ownership.xml · nonDerivative · entry 1 Patel Prashant · CIK 0001617460 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,118,247 F1 · shares: The Issuer issued the Reporting Person 5,000,000 shares of common stock (the "Shares") as compensation for the Reporting Person's service to the Issuer. The Shares were issued in a transaction exempt from registration under Section 4(a)(2) of the Securities Act of 1933. Read SEC document |
| March 31, 2026 Filed Apr 24, 2026 00:52 UTC |
AJJARAPU SURENDRA KDirector
|
GrantWarrant · Derivative | 5,000,000 | $0.01 Strike: $0.01 | $50,000.00 |
DisclosureSEC source: 0001493152-26-018817 · ownership.xml · derivative · entry 2 AJJARAPU SURENDRA K · CIK 0001368298 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,000,000 Underlying: Common Stock · 5,000,000 shares Expires 2031-03-31 F2 · shares: The Issuer issued the Reporting Person 5,000,000 warrants to purchase common stock (the "Warrants") as compensation for the Reporting Person's service to the Issuer. The Warrants were issued in a transaction exempt from registration under Section 4(a)(2) of the Securities Act of 1933. Read SEC document |
| March 31, 2026 Filed Apr 24, 2026 00:52 UTC |
AJJARAPU SURENDRA KDirector
|
GrantCommon Stock | 5,000,000 | $0.20 | $1,000,000.00 |
DisclosureSEC source: 0001493152-26-018817 · ownership.xml · nonDerivative · entry 1 AJJARAPU SURENDRA K · CIK 0001368298 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,882,247 F1 · shares: The Issuer issued the Reporting Person 5,000,000 shares of common stock (the "Shares") as compensation for the Reporting Person's service to the Issuer. The Shares were issued in a transaction exempt from registration under Section 4(a)(2) of the Securities Act of 1933. Read SEC document |
| March 31, 2026 Filed Jun 25, 2026 20:15 UTC Amendment |
Patel PrashantDirector · Chief Executive Officer
|
GrantWarrant · Derivative | 5,000,000 | $0.00 Strike: $0.00 | $500.00 |
DisclosureSEC source: 0001493152-26-030122 · ownership.xml · derivative · entry 2 Patel Prashant · CIK 0001617460 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,000,000 Underlying: Common Stock · 5,000,000 shares Expires 2031-03-31 F2 · shares: The Issuer issued the Reporting Person 5,000,000 warrants to purchase common stock (the "Warrants") as compensation for the Reporting Person's service to the Issuer. The Warrants were issued in a transaction exempt from registration under Section 4(a)(2) of the Securities Act of 1933. Read SEC document |
| March 31, 2026 Filed Jun 25, 2026 20:15 UTC Amendment |
Patel PrashantDirector · Chief Executive Officer
|
GrantCommon Stock | 5,000,000 | $0.20 | $1,000,000.00 |
DisclosureSEC source: 0001493152-26-030122 · ownership.xml · nonDerivative · entry 1 Patel Prashant · CIK 0001617460 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,118,247 F1 · shares: The Issuer issued the Reporting Person 5,000,000 shares of common stock (the "Shares") as compensation for the Reporting Person's service to the Issuer. The Shares were issued in a transaction exempt from registration under Section 4(a)(2) of the Securities Act of 1933. Read SEC document |
| March 31, 2026 Filed Jun 25, 2026 20:15 UTC Amendment |
AJJARAPU SURENDRA KDirector
|
GrantWarrant · Derivative | 5,000,000 | $0.00 Strike: $0.00 | $500.00 |
DisclosureSEC source: 0001493152-26-030123 · ownership.xml · derivative · entry 2 AJJARAPU SURENDRA K · CIK 0001368298 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,000,000 Underlying: Common Stock · 5,000,000 shares Expires 2031-03-31 F2 · shares: The Issuer issued the Reporting Person 5,000,000 warrants to purchase common stock (the "Warrants") as compensation for the Reporting Person's service to the Issuer. The Warrants were issued in a transaction exempt from registration under Section 4(a)(2) of the Securities Act of 1933. Read SEC document |
| March 31, 2026 Filed Jun 25, 2026 20:15 UTC Amendment |
AJJARAPU SURENDRA KDirector
|
GrantCommon Stock | 5,000,000 | $0.20 | $1,000,000.00 |
DisclosureSEC source: 0001493152-26-030123 · ownership.xml · nonDerivative · entry 1 AJJARAPU SURENDRA K · CIK 0001368298 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,882,247 F1 · shares: The Issuer issued the Reporting Person 5,000,000 shares of common stock (the "Shares") as compensation for the Reporting Person's service to the Issuer. The Shares were issued in a transaction exempt from registration under Section 4(a)(2) of the Securities Act of 1933. Read SEC document |
| July 02, 2025 Filed Jul 8, 2025 21:15 UTC |
PETERSON MICHAEL LDirector
|
GrantCommon Stock | 200,000 | $0.90 | $180,000.00 |
DisclosureSEC source: 0001641172-25-018239 · ownership.xml · nonDerivative · entry 1 PETERSON MICHAEL L · CIK 0001293970 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 200,000 F1 · shares: The shares shall fully vest solely on the basis of the passage of time, with 66,000 shares vesting immediately, 67,000 shares vesting on July 2, 2026, and 67,000 shares vesting on July 2, 2027. Read SEC document |
| March 21, 2025 Filed Mar 25, 2025 11:59 UTC |
Norton BrianChief Executive Officer
|
GrantCommon Stock, Par Value $0.0001 | 9,000,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001641172-25-000551 · ownership.xml · nonDerivative · entry 1 Norton Brian · CIK 0002059336 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,044,720 F1 · shares: Shares of restricted stock issued pursuant to the Wellgistics Health, Inc. Amended and Restated 2023 Equity Incentive Plan. The shares shall fully vest solely upon the achievement of certain financial metrics for the years ending December 31, 2025, 2026, and 2027. The first vesting opportunity is during the first quarter of 2026. Read SEC document |
| March 21, 2025 Filed Mar 25, 2025 16:21 UTC |
Pirani ShafaatChief Clinical Officer
|
GrantCommon Stock, Par Value $0.0001 | 35,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001641172-25-000603 · ownership.xml · nonDerivative · entry 1 Pirani Shafaat · CIK 0002058548 · Chief Clinical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 102,080 F1 · shares: Shares of restricted stock issued pursuant to the Wellgistics Health, Inc. Amended and Restated 2023 Equity Incentive Plan. The shares shall fully vest solely on the basis of the passage of time, with 15,000 shares vesting immediately, 10,000 shares vesting on October 1, 2026, and 10,000 shares vesting on October 1, 2027. Read SEC document |
| March 21, 2025 Filed Mar 25, 2025 15:53 UTC |
Syed SajidDirector
|
GrantCommon Stock, Par Value $0.0001 | 200,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001641172-25-000585 · ownership.xml · nonDerivative · entry 1 Syed Sajid · CIK 0002032263 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 244,720 F1 · shares: Shares of restricted stock issued pursuant to the Wellgistics Health, Inc. Amended and Restated 2023 Equity Incentive Plan. The shares shall fully vest solely on the basis of the passage of time, with 66,000 shares vesting immediately, 67,000 shares vesting on March 4, 2026, and 67,000 shares vesting on March 4, 2027. Read SEC document |
| March 21, 2025 Filed Mar 25, 2025 19:50 UTC |
AJJARAPU SURENDRA KDirector
|
GrantCommon Stock, Par Value $0.0001 | 600,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001641172-25-000584 · ownership.xml · nonDerivative · entry 3 AJJARAPU SURENDRA K · CIK 0001368298 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Sansur Associates LLC Disclosed balance after: 3,100,000 F1 · shares: Shares of restricted stock issued pursuant to the Wellgistics Health, Inc. Amended and Restated 2023 Equity Incentive Plan. Read SEC document |
| March 21, 2025 Filed Mar 25, 2025 19:50 UTC |
AJJARAPU SURENDRA KDirector
|
GrantCommon Stock, Par Value $0.0001 | 600,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001641172-25-000584 · ownership.xml · nonDerivative · entry 2 AJJARAPU SURENDRA K · CIK 0001368298 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By the Sandhya Ajjarapu Revocable Trust 2007 Disclosed balance after: 4,463,200 F1 · shares: Shares of restricted stock issued pursuant to the Wellgistics Health, Inc. Amended and Restated 2023 Equity Incentive Plan. Read SEC document |
| March 21, 2025 Filed Mar 25, 2025 19:50 UTC |
AJJARAPU SURENDRA KDirector
|
GrantCommon Stock, Par Value $0.0001 | 2,882,247 | $0.00 | $0.00 |
DisclosureSEC source: 0001641172-25-000584 · ownership.xml · nonDerivative · entry 1 AJJARAPU SURENDRA K · CIK 0001368298 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,822,247 F1 · shares: Shares of restricted stock issued pursuant to the Wellgistics Health, Inc. Amended and Restated 2023 Equity Incentive Plan. Read SEC document |
| March 21, 2025 Filed Mar 25, 2025 16:02 UTC |
Patel PrashantDirector · Chief Strategy Officer
|
GrantCommon Stock, Par Value $0.0001 | 700,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001641172-25-000555 · ownership.xml · nonDerivative · entry 3 Patel Prashant · CIK 0001617460 · Director · Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Indirect · By Scietech LLC Disclosed balance after: 700,000 F1 · shares: Shares of restricted stock issued pursuant to the Wellgistics Health, Inc. Amended and Restated 2023 Equity Incentive Plan. Read SEC document |
| March 21, 2025 Filed Mar 25, 2025 16:02 UTC |
Patel PrashantDirector · Chief Strategy Officer
|
GrantCommon Stock, Par Value $0.0001 | 1,500,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001641172-25-000555 · ownership.xml · nonDerivative · entry 2 Patel Prashant · CIK 0001617460 · Director · Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Indirect · By Akrias LLC Disclosed balance after: 1,500,000 F1 · shares: Shares of restricted stock issued pursuant to the Wellgistics Health, Inc. Amended and Restated 2023 Equity Incentive Plan. Read SEC document |
| March 21, 2025 Filed Mar 25, 2025 16:02 UTC |
Patel PrashantDirector · Chief Strategy Officer
|
GrantCommon Stock, Par Value $0.0001 | 1,882,247 | $0.00 | $0.00 |
DisclosureSEC source: 0001641172-25-000555 · ownership.xml · nonDerivative · entry 1 Patel Prashant · CIK 0001617460 · Director · Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,118,247 F1 · shares: Shares of restricted stock issued pursuant to the Wellgistics Health, Inc. Amended and Restated 2023 Equity Incentive Plan. Read SEC document |
| March 21, 2025 Filed Mar 25, 2025 16:00 UTC |
ANDERSON DONALD WILLIAMDirector
|
GrantCommon Stock, Par Value $0.0001 | 200,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001641172-25-000553 · ownership.xml · nonDerivative · entry 1 ANDERSON DONALD WILLIAM · CIK 0002030674 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 244,720 F1 · shares: Shares of restricted stock issued pursuant to the Wellgistics Health, Inc. Amended and Restated 2023 Equity Incentive Plan. The shares shall fully vest solely on the basis of the passage of time, with 66,000 shares vesting immediately, 67,000 shares vesting on March 4, 2026, and 67,000 shares vesting on March 4, 2027. Read SEC document |
| March 21, 2025 Filed Mar 25, 2025 15:54 UTC |
Panchal NikulChief Pharmacy Officer
|
GrantCommon Stock, Par Value $0.0001 | 90,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001641172-25-000549 · ownership.xml · nonDerivative · entry 2 Panchal Nikul · CIK 0002060092 · Chief Pharmacy Officer 10b5-1 filing: No plan indicated Ownership: Indirect · By Green Apoteker LLC Disclosed balance after: 90,000 F1 · shares: Shares of restricted stock issued pursuant to the Wellgistics Health, Inc. Amended and Restated 2023 Equity Incentive Plan. The shares shall fully vest solely on the basis of the passage of time, with 50% vesting immediately and the remaining 50% vesting on October 1, 2025. Read SEC document |
| March 21, 2025 Filed Mar 25, 2025 15:49 UTC |
SHANAHAN REBECCA MDirector
|
GrantCommon Stock, Par Value $0.0001 | 200,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001641172-25-000547 · ownership.xml · nonDerivative · entry 1 SHANAHAN REBECCA M · CIK 0001241179 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 244,720 F1 · shares: Shares of restricted stock issued pursuant to the Wellgistics Health, Inc. Amended and Restated 2023 Equity Incentive Plan. The shares shall fully vest solely on the basis of the passage of time, with 66,000 shares vesting immediately, 67,000 shares vesting on March 4, 2026, and 67,000 shares vesting on March 4, 2027. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.